1.
D'Arino A, Fargnoli MC, Frascione P, Assorgi C, Dattola A, Lora V, et al. Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series. Dermatol Reports [Internet]. 2025 Jul. 30 [cited 2026 Apr. 18];. Available from: https://journals.pagepress.net/dr/article/view/10379